The next-generation hematology platform builds on the XN-Series with higher throughput, enhanced analytics and modular workflow support for high-complexity laboratories. ...
Recent advancements around pTau217 assays are drawing significant attention for their ability to detect amyloid pathology through minimally invasive blood testing...
The designation supports Gene Solutions’ US development pathway for its multi-omic blood-based test designed to detect cancer-associated signals across 10 cancer types. ...
Open-access digital platform supports policymakers, researchers and the public in exploring the health, economic and education impacts of pandemic response strategies....
POWER CAD I study will evaluate feasibility of the Pulse IVL™ system in patients with severely calcified coronary arterial disease...
RAMP UP programme with Hitachi High-Tech America supports electronic genome mapping studies in AML and MDS ...
Collaboration aims to improve accessibility and adoption of multi-cancer early detection solutions through a broader practitioner network ...
Investment manager Michael Lamprecht highlights structural funding gaps, regulatory fragmentation, and the need for commercially viable antimicrobial resistance strategies ...
The launch of pTau217 marks a significant step in providing a simple, blood-based tool to diagnose Alzheimer's much earlier in the patient journey...
The FDA 510(k) clearance advances Biozen’s BP1000, a handheld fingertip device designed to deliver clinically validated spot blood pressure measurements without an arm cuff or per-user calibration. ...
